ASCO 2015 Highlights

Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem-Cell Transplantation for De Novo ALL in Adults

EHA 2016, EHA 2016 – Leukemia, EHA

Conference Correspondent

Response-Adapted Sequential Azacitidine and Intensive Chemotherapy Is Effective in Patients Aged >60 Years with Newly Diagnosed AML

EHA 2016, EHA 2016 – Leukemia, EHA

Conference Correspondent

Valuable New Prognostic Scoring System in Patients with CML Receiving Nilotinib as Initial Treatment

EHA 2016, EHA 2016 – Leukemia, EHA

Conference Correspondent

Venetoclax Is Safe and Effective When Combined with Rituximab in Relapsed CLL

EHA 2016, EHA 2016 – Leukemia, EHA

Conference Correspondent

A phase II open-label single-arm study of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer (NSCLC): Luret study

ASCO 2016 – Lung Cancer, ASCO

Conference Correspondent

A randomized, open label, phase II study comparing pemetrexed plus cisplatin followed by pemetrexed versus pemetrexed alone in EGFR mutant NSCLC patients who have failed first-line EGFR TKI: KCSG-LU12-13

ASCO 2016 – Lung Cancer, ASCO

Conference Correspondent

Alectinib (ALC) versus crizotinib (CRZ) in ALK-inhibitor naive ALK-positive non-small cell lung cancer (ALK+ NSCLC): Primary results from the J-ALEX study

ASCO 2016 – Lung Cancer, ASCO

Conference Correspondent

An open-label phase 2 trial of dabrafenib (D) in combination with trametinib (T) in patients (pts) with previously treated BRAF V600E–mutant advanced non-small cell lung cancer (NSCLC; BRF113928)

ASCO 2016 – Lung Cancer, ASCO

Conference Correspondent

Avelumab (MSB0010718C; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN solid tumor phase 1b trial: Safety, clinical activity, and PD-L1 expression

ASCO 2016 – Lung Cancer, ASCO

Conference Correspondent

Bayesian randomized trial comparing intensity-modulated radiation therapy versus passively scattered proton therapy for locally advanced non–small-cell lung cancer

ASCO 2016 – Lung Cancer, ASCO

Conference Correspondent

Page 163 of 330